Special Supplement
ePharma Marketing, Volume 2
Section 1: Is Pharma eMarketing at a Tipping Point?
Also see Section 2: Emerging Trends and What’s Next
This Special Supplement, published in July 2008, is available in two sections, which can be ordered separately or together in a package at a discount: Discount Package Deal
OVERVIEW
Most predictions of pharma eMarketing “tipping” or coming of age have not materialized — at least not so much as to put the drug industry on a par with other industries, which devote at least twice as much of their advertising budgets to the Internet as does the drug industry. Several of the articles in this section explore why this is so.
You’ll also find data from various sources that document the trend in pharmaceutical online spending from 2004 through the end of 2007. Also included are articles that address eMarketing return on investment (ROI) and information regarding pharmaceutical adoption of social media marketing.
38 pages…
SECTION 1 TABLE OF CONTENTS
- e-Inertia Plagues the Pharma Industry
- Pharma’s Plodding Approach to eMarketing
- Pharma Online Spending
- Marketing Mix of Leading Pharma Advertisers
- Online Pharma Marketing: Why Aren’t We There Yet?
- Helping Pharma eMarketing “Grow up”
- Pharma Marketing Stuck in Web 1.5
- Pharma’s Social Media Marketing Readiness Score
Order and pay for ePharma Marketing, Volume 2, Section 1 NOW using your credit card…
ONLY $19.95
38 pages; published July 21, 2008.
Download PDF file immediately after paying:
or Order BOTH sections 1 and 2 as a package deal at a reduced rate!
]]>
ePharma Marketing, Volume 2
Section 2: Emerging Trends and What’s Next
Also see Section 1: Is Pharma eMarketing at a Tipping Point?
This Special Supplement, published in July 2008, is available in two sections, which can be ordered separately or together in a package at a discount: Discount Package Deal
OVERVIEW
While the drug industry as a whole may lag behind other industries in embracing the Internet, several individual pharmaceutical companies are more immersed than others.
This section includes articles that focus on innovative Web-based applications that the drug industry currently sponsors for healthcare professionals and consumers.
Some examples include defining a new role for eDetailing, engaging physicians and consumers via trusted 3rd party social networking sites, and ideas for integrating the Web into traditional pharmaceutical marketing campaigns.
27 pages…
SECTION 2 TABLE OF CONTENTS
- Internet vs. Sales Reps: Which Do Docs Prefer?
- Emerging Trends in European Physician and Consumer Use of the Internet
- Closed-Loop Marketing
- Collaborating with Online Physician Communities
- Marketing to the “Long Tail Physician” Segment
- Pharma, Physicians, and Web 2.0: Are We There Yet?
- Trends Driving Physician Education and Branded Communications Online
- Surfing the eMarketing Big One!
- Blogs vs. DTC: What’s Best for Consumers?
- Revolution Health and the Wisdom of Crowds
- Got Game? Online Pharma Advergaming
- Behavioral Targeting
- Blogs are Done! What’s Next for Pharma Marketing?
Order and pay for ePharma Marketing, Volume 2, Section 2 NOW using your credit card…
ONLY $19.95
27 pages; published July 21, 2008.
Download PDF file immediately after paying:
or Order BOTH sections 1 and 2 as a package deal at a reduced rate!
]]>
ePharma Marketing, Volume 2
Section 1: Is Pharma eMarketing at a Tipping Point?
Section 2: Emerging Trends and What’s Next
Sections 1 and 2 of this Special Supplement complement each other: Section 1 offers a frank assessment of where the drug industry stands with regard to online marketing and Section 2 offers case studies and examples of best practices, trends, and where the industry may be heading in its future use of the Internet for marketing.
Order and pay for ePharma Marketing, Volume 2, Sections 1 AND 2 now and SAVE! Use your credit card…
ONLY $29.95 (SAVE $9.95!)
65 pages; published July 21, 2008.
Download PDF file immediately after paying:
]]>
